The University of Southampton
University of Southampton Institutional Repository

Changes of blood biomarkers following pre-eclampsia and predictors of future cardiovascular risk

Changes of blood biomarkers following pre-eclampsia and predictors of future cardiovascular risk
Changes of blood biomarkers following pre-eclampsia and predictors of future cardiovascular risk
Background: Pre-eclampsia (P-EC) is a major cause of maternal and neonatal mortality and morbidity. Alterations in the maternal vasculature and coagulation profile may predispose women with P-EC to subsequent deleterious cardiovascular consequences. Indeed women with a history of P-EC are known to have heightened risks of future cardiovascular disease and thromboembolic complications.Aims: To assess the relationship between circulating haemostatic factors and inflammatory cytokines in women with a previous history of P-EC.To investigate the relationship between haemostatic, angiogenic and anti-angiogenic factors in women with a past history of P-EC.To assess the plasma levels of Annexins A2 and A5 in pre-eclamptic women postpartum at different time intervals.To identify clusters of differentially expressed plasma proteins in P-EC associated with the susceptibility to developing future cardiovascular diseases.To examine miRNAs expression in P-EC post-delivery at different intervals time points.Study-I: 26 pre-eclamptic women and 14 age-matched to healthy women. Women were included within six months to 3 years post-delivery. Plasma TF, IL-6, IL-8 and IL-10 levels increased in the P-EC group, whereas plasma TFPI and TNF-α levels were reduced. Plasma TF/TFPI ratios and IL-10 values were significantly increased in the P-EC group (p<0.05, p<0.01, respectively). There were positive and significant correlations between TFPI(r= 0.5; p<0.01) and IL-10 and TF/TFPI ratio and IL-10 (r= 0.31; p<0.041).Study-II: 21 primiparous women after a pregnancy affected by P-EC and 21 women with a previously unaffected pregnancy. Blood samples were obtained at 6-12 months postpartum. Significant differences were not observed for VEGF, PlGF, sFlt-1, sEng, TF or TFPI between two groups.Study-III: 66 women who had P-EC at interval years starting from 2007, and then from 2012 till 2016 and five as a control group. Findings revealed that the level of ANXA5 was reduced in P-EC cohort, and there was an increase in levels of annexin A2, particularly in late post-delivery pre-eclamptic women, although these changes were statistically insignificant. The lack of statistical significance may be due to the small number of control compare to P-EC group.Study-IV: 5 women aged-matched with five women with normal pregnancy, results show that inflammation, immune response, blood coagulation and metabolism are dysregulated processes one-year post-delivery in women with a history of pre-eclampsia.Study-Study-V: Next-Generation Sequencing (NGS) technique was used during the discovery stage to identify miRNAs differentially expressed in P-EC postpartum (n=30) in comparison to five healthy control, then quantitative reverse transcription-polymerase chain reaction (qRT-PCR) assay used for confirmation and validation. 14 miRNAs that were significantly differentially expressed at a significance level of 0.05 (FDR) in the discovery experiment. The plasma miR-103a-3p were significantly differentially expressed in the validating experiment, which was downregulated in entire pre-eclamptic women with FC= -1.3; BH-adj P-value =0.033.Conclusions: Results suggest the presence of elevated inflammatory cytokines and an imbalance of the haemostatic system in women with a past-history of P-EC, which may contribute to the known increased risk of cardiovascular disease later in life. The proteomics findings provide insight into the dysregulated cardiometabolic profile in the P-EC group. The miRNAs novel marker pave the way for the importance of miR-103a-3p in monitoring P-EC women in the future and could be a useful tool in predicting the development of cardiovascular disease in P-EC.
University of Southampton
Abad, Fatma S.H
46a6b496-747d-42af-8cdc-ff01964485fd
Abad, Fatma S.H
46a6b496-747d-42af-8cdc-ff01964485fd
Lwaleed, Bashir
e7c59131-82ad-4a14-a227-7370e91e3f21

Abad, Fatma S.H (2020) Changes of blood biomarkers following pre-eclampsia and predictors of future cardiovascular risk. University of Southampton, Doctoral Thesis, 212pp.

Record type: Thesis (Doctoral)

Abstract

Background: Pre-eclampsia (P-EC) is a major cause of maternal and neonatal mortality and morbidity. Alterations in the maternal vasculature and coagulation profile may predispose women with P-EC to subsequent deleterious cardiovascular consequences. Indeed women with a history of P-EC are known to have heightened risks of future cardiovascular disease and thromboembolic complications.Aims: To assess the relationship between circulating haemostatic factors and inflammatory cytokines in women with a previous history of P-EC.To investigate the relationship between haemostatic, angiogenic and anti-angiogenic factors in women with a past history of P-EC.To assess the plasma levels of Annexins A2 and A5 in pre-eclamptic women postpartum at different time intervals.To identify clusters of differentially expressed plasma proteins in P-EC associated with the susceptibility to developing future cardiovascular diseases.To examine miRNAs expression in P-EC post-delivery at different intervals time points.Study-I: 26 pre-eclamptic women and 14 age-matched to healthy women. Women were included within six months to 3 years post-delivery. Plasma TF, IL-6, IL-8 and IL-10 levels increased in the P-EC group, whereas plasma TFPI and TNF-α levels were reduced. Plasma TF/TFPI ratios and IL-10 values were significantly increased in the P-EC group (p<0.05, p<0.01, respectively). There were positive and significant correlations between TFPI(r= 0.5; p<0.01) and IL-10 and TF/TFPI ratio and IL-10 (r= 0.31; p<0.041).Study-II: 21 primiparous women after a pregnancy affected by P-EC and 21 women with a previously unaffected pregnancy. Blood samples were obtained at 6-12 months postpartum. Significant differences were not observed for VEGF, PlGF, sFlt-1, sEng, TF or TFPI between two groups.Study-III: 66 women who had P-EC at interval years starting from 2007, and then from 2012 till 2016 and five as a control group. Findings revealed that the level of ANXA5 was reduced in P-EC cohort, and there was an increase in levels of annexin A2, particularly in late post-delivery pre-eclamptic women, although these changes were statistically insignificant. The lack of statistical significance may be due to the small number of control compare to P-EC group.Study-IV: 5 women aged-matched with five women with normal pregnancy, results show that inflammation, immune response, blood coagulation and metabolism are dysregulated processes one-year post-delivery in women with a history of pre-eclampsia.Study-Study-V: Next-Generation Sequencing (NGS) technique was used during the discovery stage to identify miRNAs differentially expressed in P-EC postpartum (n=30) in comparison to five healthy control, then quantitative reverse transcription-polymerase chain reaction (qRT-PCR) assay used for confirmation and validation. 14 miRNAs that were significantly differentially expressed at a significance level of 0.05 (FDR) in the discovery experiment. The plasma miR-103a-3p were significantly differentially expressed in the validating experiment, which was downregulated in entire pre-eclamptic women with FC= -1.3; BH-adj P-value =0.033.Conclusions: Results suggest the presence of elevated inflammatory cytokines and an imbalance of the haemostatic system in women with a past-history of P-EC, which may contribute to the known increased risk of cardiovascular disease later in life. The proteomics findings provide insight into the dysregulated cardiometabolic profile in the P-EC group. The miRNAs novel marker pave the way for the importance of miR-103a-3p in monitoring P-EC women in the future and could be a useful tool in predicting the development of cardiovascular disease in P-EC.

Text
1.Final corrected PhD thesis. Final - Version of Record
Available under License University of Southampton Thesis Licence.
Download (6MB)
Text
2. Permission to deposit thesis - signed
Restricted to Repository staff only

More information

Published date: July 2020

Identifiers

Local EPrints ID: 447730
URI: http://eprints.soton.ac.uk/id/eprint/447730
PURE UUID: 47b902ae-58a1-499a-ae5b-8703382919ae

Catalogue record

Date deposited: 19 Mar 2021 17:30
Last modified: 12 Dec 2021 13:21

Export record

Contributors

Author: Fatma S.H Abad
Thesis advisor: Bashir Lwaleed

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×